Curevac Stock Price Target

CureVac NVs average analyst price target is greater than 8745 of Pharmaceutical Products stocks. Credit Suisse have made an estimate for CureVac NV.

Curevac Provides Update On Phase 2b 3 Trial Of First Generation Covid 19 Vaccine Candidate Cvncov Curevac

As of Sep 10.

Curevac stock price target. A break of a horizontal trend is often followed by a large increase in the volume and stocks seldom manage to go directly from the bottom of a trend up to the top. The new note on the price target was released on April 26 2021 representing the official price target for CureVac NV. Given the current horizontal trend you can expect Curevac NV.

Shares are logging -7364 during the 52-week period from high price and -570 higher than the lowest price point for the same timeframe. Previously the target price had yet another drop from 50 to 47 while Credit Suisse kept a Underperform rating on CVAC stock. Find the latest CureVac NV.

When setting a price target estimate an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally the target price of Curevac depends on its intrinsic valuation beta ie risk over market and overall volatility. 3 Wall Street analysts have set twelve-month price targets for CureVac in the last year.

CVAC a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid mRNA today announced the publication of its pivotal Phase 2b3 HERALD study. The average twelve-month price target for CureVac is 7333 with a high price target of 12300 and a low price target of 4700. Our community is currently high on Curevac NV.

Price Target is 50. The current price is about 1396 off the estimated. BofA Securities Downgrades CureVac to Neutral From Buy.

In order for the stock price to hit the forecast high the stock would need to plunge -16678 from its current level while the. Today 52-Week Range. Stocks turning up in the middle of a horizontal trend are therefore.

Compared to the current price of 4692. The stocks price range for the 52-week period managed to maintain. To hit the forecast high the stocks price needs a -12504 plunge from its current level while the stock would need to tank 947 for it to hit the projected low.

The average price target is 59 which means analysts expect the stock to add by 4507 over the next twelve months. The new note on the price target was released on September 08 2020 representing the official price target for CureVac NV. The consensus price target as assigned by Wall Street analysts is 6872 which translates to bulls needing to increase their stock price by 4214 from its current value.

Stock news by MarketWatch. Find the latest CureVac NV. According to analysts consensus price target of 7333 CureVac has a forecasted upside of 675 from its current price of 4377.

Quote is equal to 56060 USD at 2021-09-29. CVAC analyst stock forecast price target and recommendation trends with in-depth analysis from research reports. With 23 Buy predictions and 5 Sell predictions.

Gained 0290 compared to yesterday. View real-time stock prices and stock quotes for a full financial overview. In terms of price targets and recommendations offered by analysts the stocks in the Pharmaceutical Products industry with the ratings most similar to CureVac NV are OGN ANAB and AMPH.

With a target price of 8000 there is a hugely positive potential of 70521 for Curevac NV. TÜBINGEN Germany BOSTON USA - August 31 2021 - CureVac NV. Can be a profitable investment option.

What is the current price target for CureVac. NASDAQCVACs beta value is currently sitting at 0 while the Average True Range indicator is currently displaying 309. CVAC stock forecast and price target.

According to analyst projections CVACs forecast low is 4216 with 10480 as the target high. CVAC stock quote history news and other vital information to help you with your stock trading and investing. On average analysts give CureVac BV a Hold rating.

Price Target Upside Daily Upgrade. With analysts defining 3543-10607 as the low and high price targets we arrive at a consensus price target of 6554 for the trailing 12-month period. What is CVACs Price Target.

While these analysts kept the previous recommendation Credit Suisse raised their target price to Neutral. According to 1 Wall Street analysts that have issued a 1 year CVAC price target the average CVAC price target is 5000 with the highest CVAC stock price forecast at 5000 and the lowest CVAC stock price forecast at 5000. Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stocks existing status and the future performance.

Based on our forecasts a long-term increase is expected the CVAC stock price prognosis for 2026-09-21 is 87302 USD. Most analysts publish their price targets in research reports on specific companies along with their buy hold or sell recommendations. Shares keeping their opinion on the stock as Underperform with their previous recommendation back on April 26 2021.

Previously the target price had yet another raise to 70 while BofA Securities analysts kept a Buy rating on CVAC stock. Stock with a 90 probability to be traded between 4193 and 7265 at the end of this 3-month period. That average ranking earns CureVac BV an Analyst Rating of 4 which is better than 4 of stocks based on data compiled by InvestorsObserver.

Analyst projections state that CVAC is forecast to be at a low of 4496 and a high of 10607. If you are looking for stocks with good return CureVac NV. Amount of Analyst Coverage CureVac has received no research coverage in the past 90 days.

CureVacs CVnCoV Phase 2b3 Study Data Published in Preprints with The Lancet. Their average twelve-month price target is 7333. According to the issued ratings of 5 analysts in the last year the consensus rating for CureVac stock is Hold based on the current 1 sell rating 1 hold rating and 3 buy ratings for CVAC.

Our community identified positive and negative. CVAC Complete CureVac NV.

Tm2016252 23 424b4 None 46 55952s

Tesla Backed Vaccine Stock Gets First Sell After 752 Rally

Tm2016252 23 424b4 None 46 55952s

Https Static Dw Com Image 56361558 7 Png

Tm2016252 23 424b4 None 46 55952s

Is Curevac Stock Still A Buy Following Disappointing Covid 19 Vaccine Data Nasdaq

Tm2016252 23 424b4 None 46 55952s

Stocks Making The Biggest Moves In The Premarket Glaxosmithkline Curevac Airbnb And More

Https Www Ft Com Origami Service Image V2 Images Raw Https 3a 2f 2fd6c748xw2pzm8 Cloudfront Net 2fprod 2f7f719b40 C9fe 11eb 95ba Afd56df2ea97 Standard Png Dpr 1 Fit Scale Down Quality Highest Source Next Width 700

Curevac Overvalued But Can Pop Again Nasdaq Cvac Seeking Alpha

Stocks Near Record Highs On Recovery Hopes Curevac Sinks Reuters

Curevac N V Cvac Stock Price Nl0015436031 Marketscreener

Https Www Ft Com Origami Service Image V2 Images Raw Https 3a 2f 2fd6c748xw2pzm8 Cloudfront Net 2fprod 2fb3cb3f90 C9fe 11eb 8a24 D183036ed9cb Standard Png Dpr 1 Fit Scale Down Quality Highest Source Next Width 700

Stocks Near Record Highs On Recovery Hopes Curevac Sinks Reuters